MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

BQ-788 sodium salt

CAS No. : 156161-89-6

MCE 站：BQ-788 sodium salt

产品活性：BQ-788 sodium salt 是一种有效，选择性的 ETB 受体拮抗剂，在人类 Girrardi 心脏细胞中抑制 ET-1 与 ETB 受体结合的 IC₅₀ 为 1.2 nM。

研究领域：GPCR/G Protein

作用靶点：Endothelin Receptor

In Vitro: BQ-788 potently and competitively inhibits ¹²⁵I-labeled ET-1 binding to ETB receptors in human Girrardi heart cells with an IC₅₀ of 1.2 nM, but only poorly inhibits the binding to ETA receptors in human neuro-blastoma cell line SK-N-MC cells (IC₅₀, 1300 nM). BQ-788 shows no agonistic activity up to 10 μM and competitively inhibits thevasoconstriction induced by an ETB-selective agonist (pA2, 8.4). BQ-788 also inhibits several bioactivities of ET-1, such as bronchoconstriction, cell proliferation, and clearance of perfused ET-1.

In Vivo: BQ-788 (3 mg/kg/h, i.v.) completely inhibits a pharmacological dose of ET-1- or sarafotoxin6c (0.5 nmol/kg, i.v.)-induced ETB receptor-mediated depressor, but not pressor responses in conscious rats. Furthermore, BQ-788 markedly increases the plasma concentration of ET-1, which is considered an index of potential ETB receptor blockade in vivo. In Dahl salt-sensitive hypertensive (DS) rats, BQ-788 (3 mg/kg/h, i.v.) increases blood pressure by about 20 mm Hg. It is reported that BQ-788 also inhibits ET-1-induced bronchoconstriction, tumor growth and lipopolysaccharide-induced organfailure. BQ 788 (3 mg/kg) results in an eightfold leftward shift in the ET-1 dose-response curve, suggesting a significant involvement of ETB dilator receptors. Mice are treated with 30 nmol BQ-788 by intraplantar, reduce mechanical hyperalgesia (47% and 42%), thermal hyperalgesia (68% and 76%), oedema (50% and 30%); myeloperoxidase activity (64% and 32%), and overt-pain like behaviours. Additionally, intraplantar treatment with clazosentan or BQ-788 decreases spinal (45% and 41%) and peripheral (47% and 47%) superoxide anion production as well as spinal (47% and 47%) and peripheral (33% and 54%) lipid peroxidation, respectively.

相关产品：Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Peptidomimetic Library  |  Endothelin 1 (swine, human)  |  Bosentan  |  BQ-123  |  Atrasentan hydrochloride  |  Sparsentan  |  Ambrisentan  |  Atrial Natriuretic Peptide (ANP) (1-28), human, porcine Acetate  |  Sulfisoxazole  |  Atrial Natriuretic Peptide (ANP) (1-28), rat  |  Avosentan  |  Zibotentan  |  Darusentan  |  Sitaxsentan sodium  |  A-192621  |  IRL 2500  |  BQ-3020 TFA  |  IRL-1620  |  Nebentan  |  Tezosentan  |  ABT-546  |  Aminaftone  |  Aprocitentan D4  |  BMS-248360  |  BQ-788

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。